PDT Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-28,254
Closed -$696K 662
2022
Q3
$696K Sell
28,254
-38,411
-58% -$1.27M 0.11% 323
2022
Q2
$2.13M Buy
66,665
+46,065
+224% +$1.69M 0.19% 161
2022
Q1
$648K Buy
+20,600
New +$644K 0.06% 506
2021
Q4
Sell
-29,034
Closed -$844K 879
2021
Q3
$844K Buy
+29,034
New +$940K 0.06% 378
2019
Q4
Sell
-66,330
Closed -$991K 715
2019
Q3
$991K Buy
+66,330
New +$1.08M 0.06% 282
2018
Q2
Sell
-72,315
Closed -$3.52M 516
2018
Q1
$3.52M Sell
72,315
-488,485
-87% -$24.4M 0.12% 199
2017
Q4
$28.1M Buy
560,800
+86,300
+18% +$4.52M 0.81% 31
2017
Q3
$24M Sell
474,500
-116,800
-20% -$5.51M 0.79% 29
2017
Q2
$22.4M Buy
591,300
+75,635
+15% +$2.98M 0.9% 28
2017
Q1
$19.9M Buy
+515,665
New +$15.5M 1.04% 10
2015
Q4
Sell
-559,957
Closed -$3.62M 479
2015
Q3
$3.62M Buy
+559,957
New +$5.86M 0.08% 293

Other funds holding CC

PDT Partners's CC Position: Q4 2022 in Review

PDT Partners sold out of Chemours (CC) in Q4 2022, closing a stake of 28,254 shares — an estimated $696K sold.

PDT Partners first reported a position in CC in Q3 2015 and held it in 11 quarters. The position peaked at $28.1M in Q4 2017. 473 funds tracked by Wall St. Rank hold CC as of Q4 2022.

  • PDT Partners reported no remaining Chemours position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 28,254 Chemours shares in Q4 2022, an estimated $696K.
  • PDT Partners first reported a position in Chemours in Q3 2015 and held it in 11 quarters.
  • PDT Partners's Chemours position peaked at $28.1M in Q4 2017.
  • 473 funds tracked by Wall St. Rank held Chemours as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.